Pricing Log in Create free account

Medicus Pharma Ltd (MDCX) vs MIRA Pharmaceuticals, Inc. (MIRA)

Medicus Pharma Ltd and MIRA Pharmaceuticals, Inc. are both Drug Manufacturers General companies. MIRA Pharmaceuticals, Inc. is the larger, with a market value of $22.7M against $3.5M — 6.5× the size. Across the 9 metrics below, Medicus Pharma Ltd leads on 5 and MIRA Pharmaceuticals, Inc. on 4.

Valuation

Metric MDCX MIRA Drug Manufacturers General median
P/E n/m n/m 26.51
P/S n/m n/m 3.49
P/B n/m 2.88 5.28
Price to free cash flow n/m n/m 21.67
EV/EBITDA n/m n/m 14.73
EV/Sales n/m n/m 4.15
Earnings yield (6,473.68%) (254.29%) 2.41%
Free cash flow yield (1,401.47%) (19.71%) 4.07%

Profitability

Metric MDCX MIRA Drug Manufacturers General median
Gross margin — — 73.01%
Operating margin 0.00% 0.00% 18.34%
Net margin 0.00% 0.00% 7.31%
Free cash flow margin 0.00% 0.00% 18.56%
Return on equity (7,441.07%) (710.85%) 5.80%
Return on assets (290.34%) (684.27%) 2.28%
Return on invested capital (2,497.51%) (12,016.10%) 6.26%

Growth

Metric MDCX MIRA Drug Manufacturers General median
Revenue growth (TTM) — — 6.72%
EPS growth (last fiscal year) (136.21%) (164.71%) 21.81%
Revenue growth, 5-year CAGR — — 4.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric MDCX MIRA Drug Manufacturers General median
Debt to equity (10.42) 0.00 0.62
Current ratio 1.57 200.19 1.39
Net debt to EBITDA 0.25 1.05 1.15

Dividend

Metric MDCX MIRA Drug Manufacturers General median
Dividend yield — — 2.32%
Payout ratio — — 0.59

Size

Metric MDCX MIRA Drug Manufacturers General median
Market cap 3.47m 22.70m 129.04b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack